nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—CHUK—Signaling by EGFR—PDGFB—meningioma	0.00362	0.00362	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—PDGFB—meningioma	0.00359	0.00359	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ALAD—meningioma	0.00358	0.00358	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—PDGFB—meningioma	0.00357	0.00357	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PDGFB—meningioma	0.00347	0.00347	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—PDGFB—meningioma	0.00345	0.00345	CbGpPWpGaD
Mesalazine—IKBKB—TWEAK Signaling Pathway—AKT1—meningioma	0.00345	0.00345	CbGpPWpGaD
Mesalazine—PPARG—Wnt Signaling Pathway Netpath—AKT1—meningioma	0.00341	0.00341	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—PDGFB—meningioma	0.00338	0.00338	CbGpPWpGaD
Mesalazine—CHUK—FoxO family signaling—AKT1—meningioma	0.00336	0.00336	CbGpPWpGaD
Mesalazine—CHUK—PI-3K cascade—PTEN—meningioma	0.00335	0.00335	CbGpPWpGaD
Mesalazine—IKBKB—Interleukin-11 Signaling Pathway—AKT1—meningioma	0.00332	0.00332	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—PDGFB—meningioma	0.00331	0.00331	CbGpPWpGaD
Mesalazine—CHUK—PI3K/AKT activation—PTEN—meningioma	0.00327	0.00327	CbGpPWpGaD
Mesalazine—CHUK—GAB1 signalosome—PTEN—meningioma	0.00324	0.00324	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—PDGFB—meningioma	0.00323	0.00323	CbGpPWpGaD
Mesalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—PTEN—meningioma	0.00317	0.00317	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling in naïve CD8+ T cells—AKT1—meningioma	0.00316	0.00316	CbGpPWpGaD
Mesalazine—CHUK—IL-4 Signaling Pathway—AKT1—meningioma	0.00311	0.00311	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—PGR—meningioma	0.00311	0.00311	CbGpPWpGaD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—meningioma	0.0031	0.0031	CbGpPWpGaD
Mesalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—meningioma	0.00309	0.00309	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD34—meningioma	0.00307	0.00307	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—PDGFB—meningioma	0.00306	0.00306	CbGpPWpGaD
Mesalazine—CHUK—Cardiac Hypertrophic Response—AKT1—meningioma	0.00306	0.00306	CbGpPWpGaD
Mesalazine—CHUK—RANKL/RANK Signaling Pathway—AKT1—meningioma	0.00306	0.00306	CbGpPWpGaD
Mesalazine—CHUK—IL-1 signaling pathway—AKT1—meningioma	0.00306	0.00306	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CTSL—meningioma	0.00305	0.00305	CbGpPWpGaD
Mesalazine—IKBKB—FoxO family signaling—AKT1—meningioma	0.00305	0.00305	CbGpPWpGaD
Mesalazine—CHUK—p75(NTR)-mediated signaling—TP53—meningioma	0.00303	0.00303	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—ERBB2—meningioma	0.00294	0.00294	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CTSL—meningioma	0.00293	0.00293	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD8+ T cells—AKT1—meningioma	0.00286	0.00286	CbGpPWpGaD
Mesalazine—CHUK—Fc-epsilon receptor I signaling in mast cells—AKT1—meningioma	0.00282	0.00282	CbGpPWpGaD
Mesalazine—IKBKB—IL-4 Signaling Pathway—AKT1—meningioma	0.00282	0.00282	CbGpPWpGaD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—meningioma	0.00281	0.00281	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—ERBB2—meningioma	0.00281	0.00281	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD34—meningioma	0.00279	0.00279	CbGpPWpGaD
Mesalazine—IKBKB—Cardiac Hypertrophic Response—AKT1—meningioma	0.00278	0.00278	CbGpPWpGaD
Mesalazine—IKBKB—IL-1 signaling pathway—AKT1—meningioma	0.00278	0.00278	CbGpPWpGaD
Mesalazine—IKBKB—RANKL/RANK Signaling Pathway—AKT1—meningioma	0.00278	0.00278	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CTSL—meningioma	0.00277	0.00277	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—ERBB2—meningioma	0.00276	0.00276	CbGpPWpGaD
Mesalazine—CHUK—Immune System—AP1B1—meningioma	0.00276	0.00276	CbGpPWpGaD
Mesalazine—IKBKB—p75(NTR)-mediated signaling—TP53—meningioma	0.00274	0.00274	CbGpPWpGaD
Mesalazine—PPARG—SREBP signalling—AKT1—meningioma	0.00272	0.00272	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CTSL—meningioma	0.00266	0.00266	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling in naïve CD4+ T cells—AKT1—meningioma	0.00265	0.00265	CbGpPWpGaD
Mesalazine—CHUK—AGE/RAGE pathway—AKT1—meningioma	0.00265	0.00265	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—ERBB2—meningioma	0.00264	0.00264	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—ERBB2—meningioma	0.00263	0.00263	CbGpPWpGaD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—AKT1—meningioma	0.00262	0.00262	CbGpPWpGaD
Mesalazine—CHUK—BCR signaling pathway—AKT1—meningioma	0.00262	0.00262	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—ERBB2—meningioma	0.00261	0.00261	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—ERBB2—meningioma	0.0026	0.0026	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—TP53—meningioma	0.00259	0.00259	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—meningioma	0.00256	0.00256	CbGpPWpGaD
Mesalazine—IKBKB—Fc-epsilon receptor I signaling in mast cells—AKT1—meningioma	0.00256	0.00256	CbGpPWpGaD
Mesalazine—CHUK—p75(NTR)-mediated signaling—AKT1—meningioma	0.00256	0.00256	CbGpPWpGaD
Mesalazine—CHUK—Disease—AP1B1—meningioma	0.00255	0.00255	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—PTEN—meningioma	0.0025	0.0025	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—AP1B1—meningioma	0.0025	0.0025	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—PDGFB—meningioma	0.00249	0.00249	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—ERBB2—meningioma	0.00245	0.00245	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—ERBB2—meningioma	0.00245	0.00245	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—ERBB2—meningioma	0.00245	0.00245	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—ERBB2—meningioma	0.00243	0.00243	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—ERBB2—meningioma	0.0024	0.0024	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD4+ T cells—AKT1—meningioma	0.0024	0.0024	CbGpPWpGaD
Mesalazine—IKBKB—mTOR signaling pathway—AKT1—meningioma	0.0024	0.0024	CbGpPWpGaD
Mesalazine—IKBKB—AGE/RAGE pathway—AKT1—meningioma	0.0024	0.0024	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—PTEN—meningioma	0.0024	0.0024	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—ERBB2—meningioma	0.00239	0.00239	CbGpPWpGaD
Mesalazine—CHUK—Leptin signaling pathway—AKT1—meningioma	0.00239	0.00239	CbGpPWpGaD
Mesalazine—IKBKB—BCR signaling pathway—AKT1—meningioma	0.00237	0.00237	CbGpPWpGaD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—AKT1—meningioma	0.00237	0.00237	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—PTEN—meningioma	0.00237	0.00237	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—PTEN—meningioma	0.00236	0.00236	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—TP53—meningioma	0.00234	0.00234	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—meningioma	0.00233	0.00233	CbGpPWpGaD
Mesalazine—IKBKB—p75(NTR)-mediated signaling—AKT1—meningioma	0.00232	0.00232	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—TSHB—meningioma	0.00231	0.00231	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.0023	0.0023	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—ERBB2—meningioma	0.00227	0.00227	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—PDGFB—meningioma	0.00226	0.00226	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—PTEN—meningioma	0.00225	0.00225	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—PTEN—meningioma	0.00224	0.00224	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—PTEN—meningioma	0.00223	0.00223	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—ERBB2—meningioma	0.00222	0.00222	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—PTEN—meningioma	0.00222	0.00222	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ALAD—meningioma	0.00222	0.00222	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis Modulation and Signaling—TP53—meningioma	0.0022	0.0022	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—PTEN—meningioma	0.00219	0.00219	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—AKT1—meningioma	0.00218	0.00218	CbGpPWpGaD
Mesalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—AKT1—meningioma	0.00218	0.00218	CbGpPWpGaD
Mesalazine—IKBKB—Leptin signaling pathway—AKT1—meningioma	0.00217	0.00217	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—ERBB2—meningioma	0.00217	0.00217	CbGpPWpGaD
Mesalazine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—AKT1—meningioma	0.00214	0.00214	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—PTEN—meningioma	0.00209	0.00209	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—PTEN—meningioma	0.00209	0.00209	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	0.00209	0.00209	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—PTEN—meningioma	0.00207	0.00207	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—AKT1—meningioma	0.00207	0.00207	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—ERBB2—meningioma	0.00205	0.00205	CbGpPWpGaD
Mesalazine—IKBKB—Insulin Signaling—PTEN—meningioma	0.00205	0.00205	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—PTEN—meningioma	0.00205	0.00205	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—PTEN—meningioma	0.00204	0.00204	CbGpPWpGaD
Mesalazine—CHUK—TNF alpha Signaling Pathway—AKT1—meningioma	0.00203	0.00203	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—PTEN—meningioma	0.00201	0.00201	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—HES1—meningioma	0.002	0.002	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PTEN—meningioma	0.00198	0.00198	CbGpPWpGaD
Mesalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—AKT1—meningioma	0.00198	0.00198	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—AKT1—meningioma	0.00198	0.00198	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00196	0.00196	CbGpPWpGaD
Mesalazine—CHUK—B Cell Receptor Signaling Pathway—AKT1—meningioma	0.00195	0.00195	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—PTEN—meningioma	0.00193	0.00193	CbGpPWpGaD
Mesalazine—CHUK—PI-3K cascade—AKT1—meningioma	0.00193	0.00193	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	0.00189	0.00189	CbGpPWpGaD
Mesalazine—CHUK—PI3K/AKT activation—AKT1—meningioma	0.00188	0.00188	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—AKT1—meningioma	0.00187	0.00187	CbGpPWpGaD
Mesalazine—CHUK—GAB1 signalosome—AKT1—meningioma	0.00187	0.00187	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—AKT1—meningioma	0.00187	0.00187	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD34—meningioma	0.00186	0.00186	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	0.00185	0.00185	CbGpPWpGaD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—AKT1—meningioma	0.00184	0.00184	CbGpPWpGaD
Mesalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—meningioma	0.00183	0.00183	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CTSL—meningioma	0.00178	0.00178	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Receptor Signaling Pathway—AKT1—meningioma	0.00176	0.00176	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—PTEN—meningioma	0.00175	0.00175	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—AKT1—meningioma	0.0017	0.0017	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD34—meningioma	0.00169	0.00169	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—ERBB2—meningioma	0.00167	0.00167	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—TP53—meningioma	0.00162	0.00162	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CTSL—meningioma	0.00161	0.00161	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ALAD—meningioma	0.00155	0.00155	CbGpPWpGaD
Mesalazine—CHUK—Disease—CST3—meningioma	0.00152	0.00152	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—ERBB2—meningioma	0.00151	0.00151	CbGpPWpGaD
Mesalazine—PTGS2—Disease—AP1B1—meningioma	0.00151	0.00151	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—PGR—meningioma	0.0015	0.0015	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	0.00146	0.00146	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—AKT1—meningioma	0.00144	0.00144	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—TSHB—meningioma	0.00143	0.00143	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—PTEN—meningioma	0.00142	0.00142	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—PDGFB—meningioma	0.00142	0.00142	CbGpPWpGaD
Mesalazine—CHUK—BDNF signaling pathway—AKT1—meningioma	0.00142	0.00142	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.00141	0.00141	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—AKT1—meningioma	0.00138	0.00138	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—TP53—meningioma	0.00137	0.00137	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—AKT1—meningioma	0.00137	0.00137	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.00136	0.00136	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—PDGFB—meningioma	0.00136	0.00136	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—AKT1—meningioma	0.00136	0.00136	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TP53—meningioma	0.00135	0.00135	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.00134	0.00134	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	0.00132	0.00132	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—AKT1—meningioma	0.0013	0.0013	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—AKT1—meningioma	0.00129	0.00129	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—PTEN—meningioma	0.00129	0.00129	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—PDGFB—meningioma	0.00129	0.00129	CbGpPWpGaD
Mesalazine—IKBKB—BDNF signaling pathway—AKT1—meningioma	0.00129	0.00129	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—AKT1—meningioma	0.00128	0.00128	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—AKT1—meningioma	0.00128	0.00128	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.00126	0.00126	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—PDGFB—meningioma	0.00124	0.00124	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ALAD—meningioma	0.00123	0.00123	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—AKT1—meningioma	0.0012	0.0012	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.0012	0.0012	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—AKT1—meningioma	0.0012	0.0012	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—AKT1—meningioma	0.00119	0.00119	CbGpPWpGaD
Mesalazine—IKBKB—Insulin Signaling—AKT1—meningioma	0.00118	0.00118	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—AKT1—meningioma	0.00118	0.00118	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—AKT1—meningioma	0.00118	0.00118	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TP53—meningioma	0.00117	0.00117	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00116	0.00116	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—ERBB2—meningioma	0.00115	0.00115	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.00114	0.00114	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—AKT1—meningioma	0.00114	0.00114	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.00113	0.00113	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TSHB—meningioma	0.00112	0.00112	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—AKT1—meningioma	0.00111	0.00111	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.00109	0.00109	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.00107	0.00107	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TSHB—meningioma	0.00102	0.00102	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—AKT1—meningioma	0.00101	0.00101	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—TSHB—meningioma	0.001	0.001	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SMO—meningioma	0.000953	0.000953	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—ERBB2—meningioma	0.000951	0.000951	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PGR—meningioma	0.000914	0.000914	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—ERBB2—meningioma	0.000913	0.000913	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CST3—meningioma	0.000898	0.000898	CbGpPWpGaD
Mesalazine—CHUK—Disease—HES1—meningioma	0.000892	0.000892	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000874	0.000874	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SMO—meningioma	0.000864	0.000864	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—ERBB2—meningioma	0.000862	0.000862	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PGR—meningioma	0.000829	0.000829	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—ERBB2—meningioma	0.000828	0.000828	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PDGFB—meningioma	0.000826	0.000826	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—AKT1—meningioma	0.000819	0.000819	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—PTEN—meningioma	0.000811	0.000811	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—TSHB—meningioma	0.000794	0.000794	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000794	0.000794	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—PTEN—meningioma	0.000779	0.000779	CbGpPWpGaD
Mesalazine—CHUK—Disease—PDGFB—meningioma	0.000763	0.000763	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PDGFB—meningioma	0.000749	0.000749	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—AKT1—meningioma	0.000743	0.000743	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—PTEN—meningioma	0.000735	0.000735	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—PTEN—meningioma	0.000706	0.000706	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.00067	0.00067	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PTEN—meningioma	0.000628	0.000628	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HES1—meningioma	0.000625	0.000625	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000612	0.000612	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HES1—meningioma	0.000566	0.000566	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—AKT1—meningioma	0.000564	0.000564	CbGpPWpGaD
Mesalazine—CHUK—Immune System—ERBB2—meningioma	0.000554	0.000554	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PDGFB—meningioma	0.000534	0.000534	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HES1—meningioma	0.000528	0.000528	CbGpPWpGaD
Mesalazine—CHUK—Disease—ERBB2—meningioma	0.000511	0.000511	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—ERBB2—meningioma	0.000502	0.000502	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000486	0.000486	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PDGFB—meningioma	0.000484	0.000484	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PTEN—meningioma	0.000472	0.000472	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—AKT1—meningioma	0.000467	0.000467	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PDGFB—meningioma	0.000452	0.000452	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—AKT1—meningioma	0.000449	0.000449	CbGpPWpGaD
Mesalazine—CHUK—Disease—PTEN—meningioma	0.000436	0.000436	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PTEN—meningioma	0.000428	0.000428	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—AKT1—meningioma	0.000424	0.000424	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—AKT1—meningioma	0.000407	0.000407	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTEN—meningioma	0.000389	0.000389	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—AKT1—meningioma	0.000362	0.000362	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ERBB2—meningioma	0.000358	0.000358	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ERBB2—meningioma	0.000325	0.000325	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PTEN—meningioma	0.000305	0.000305	CbGpPWpGaD
Mesalazine—PTGS2—Disease—ERBB2—meningioma	0.000303	0.000303	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—AKT1—meningioma	0.000288	0.000288	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PTEN—meningioma	0.000277	0.000277	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTEN—meningioma	0.000273	0.000273	CbGpPWpGaD
Mesalazine—CHUK—Immune System—AKT1—meningioma	0.000272	0.000272	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PTEN—meningioma	0.000258	0.000258	CbGpPWpGaD
Mesalazine—CHUK—Disease—AKT1—meningioma	0.000251	0.000251	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—AKT1—meningioma	0.000247	0.000247	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—AKT1—meningioma	0.000224	0.000224	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PTEN—meningioma	0.000216	0.000216	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—meningioma	0.000208	0.000208	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—meningioma	0.000189	0.000189	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—AKT1—meningioma	0.000176	0.000176	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—AKT1—meningioma	0.00016	0.00016	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—AKT1—meningioma	0.000157	0.000157	CbGpPWpGaD
Mesalazine—PTGS2—Disease—AKT1—meningioma	0.000149	0.000149	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—AKT1—meningioma	0.000125	0.000125	CbGpPWpGaD
